These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28423573)
21. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer. Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614 [TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cheung LW; Leung PC; Wong AS Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127 [TBL] [Abstract][Full Text] [Related]
23. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204 [TBL] [Abstract][Full Text] [Related]
24. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer. Tang W; Ren A; Xiao H; Sun H; Li B Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706 [TBL] [Abstract][Full Text] [Related]
25. Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway. Ke Z; Caiping S; Qing Z; Xiaojing W Med Oncol; 2015 Jan; 32(1):368. PubMed ID: 25432698 [TBL] [Abstract][Full Text] [Related]
26. Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway. Co NN; Tsang WP; Wong TW; Cheung HH; Tsang TY; Kong SK; Kwok TT Mol Cancer Ther; 2008 Oct; 7(10):3160-8. PubMed ID: 18852119 [TBL] [Abstract][Full Text] [Related]
27. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition. Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014 [TBL] [Abstract][Full Text] [Related]
28. Adenovirus‑mediated overexpression of cystic fibrosis transmembrane conductance regulator enhances invasiveness and motility of serous ovarian cancer cells. Xu J; Lin L; Yong M; Dong X; Yu T; Hu L Mol Med Rep; 2016 Jan; 13(1):265-72. PubMed ID: 26549617 [TBL] [Abstract][Full Text] [Related]
29. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654 [TBL] [Abstract][Full Text] [Related]
30. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062 [TBL] [Abstract][Full Text] [Related]
31. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
33. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition. Yu J; Han Q; Cui Y Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335 [TBL] [Abstract][Full Text] [Related]
35. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475 [TBL] [Abstract][Full Text] [Related]
36. Smad7 maintains epithelial phenotype of ovarian cancer stem-like cells and supports tumor colonization by mesenchymal-epithelial transition. Li Y; Gong W; Ma X; Sun X; Jiang H; Chen T Mol Med Rep; 2015 Jan; 11(1):309-16. PubMed ID: 25333457 [TBL] [Abstract][Full Text] [Related]
37. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Law AY; Wong CK Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259 [TBL] [Abstract][Full Text] [Related]
38. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]. Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553 [TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling. Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374 [TBL] [Abstract][Full Text] [Related]
40. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]